Viokace — CareFirst (Caremark)
Exocrine pancreatic insufficiency due to pancreatectomy
Initial criteria
- The requested drug is being prescribed for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis, chronic pancreatitis, pancreatectomy, or other conditions
- If the request is for Viokace, the patient will take Viokace in combination with a proton pump inhibitor (PPI)
Approval duration
12 months